MichaelHermanChuiMD

PubMed

• 1 citations
  Mixed Ovarian Neoplasms With Gastrointestinal-type Mucinous and Mullerian Epithelial Components: A Rare Group of Tumors Demonstrating the Phenotypic Plasticity of the ...
  Michael Herman Chui, Lora H Ellenson> ;The American Journal of Surgical Pathology. 2023 Jul 1
• 7 citations
  Deep Interactive Learning-based ovarian cancer segmentation of H&E-stained whole slide images to study morphological patterns of BRCA mutation.
  David Joon Ho, M Herman Chui, Chad M Vanderbilt, Jiwon Jung, Mark E Robson, Chan-Sik Park, Jin Roh, Thomas J Fuchs> ;Journal of Pathology Informatics. 2023 Jan 1
• 2 citations
  Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors.
  Amir Momeni Boroujeni, Elizabeth Kertowidjojo, Xinyu Wu, Robert A Soslow, Sarah Chiang, Edaise M Da Silva, Britta Weigelt, M Herman Chui> ;Modern Pathology. 2022 Nov 1
• 24 citations
  MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma.
  Beryl Manning-Geist, Sushmita Gordhandas, Ying L Liu, Qin Zhou, Alexia Iasonos, Arnaud Da Cruz Paula, Diana Mandelker, Kara Long Roche, Oliver Zivanovic, Anna Maio, Ye...> ;Clinical Cancer Research. 2022 Oct 14
• 2 citations
  GermlineDeletion as a Driver of Uterine Cancer: An Atypical Presentation.
  Duaa H Al-Rawi, Vicky Makker, Britta Weigelt, Dmitriy Zamarin, Ying Liu, Angela G Arnold, M Herman Chui, Diana L Mandelker, Michael Walsh, Deborah F DeLair, Karen A Ca...> ;JCO Precision Oncology. 2022 Oct 1
• 4 citations
  Advancements in Low-Grade Serous Carcinoma of the Ovary and Peritoneum.
  Rachel N Grisham, M Herman Chui> ;Current Oncology Reports. 2022 Nov 1
• 22 citations
  Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas.
  Dara S Ross, Kelly A Devereaux, Cao Jin, David YunTe Lin, Yanming Zhang, Antonio Marra, Vicky Makker, Britta Weigelt, Lora H Ellenson, M Herman Chui> ;Modern Pathology. 2022 Jul 1
• 8 citations
  Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer.
  Sushmita B Gordhandas, Beryl Manning-Geist, Christina Henson, Gopa Iyer, Ginger J Gardner, Yukio Sonoda, Kathleen N Moore, Carol Aghajanian, M Herman Chui, Rachel N Gr...> ;Scientific Reports. 2022 Jan 19
• Metastatic melanoma concurrent to the urinary bladder and endometrium: Case report.
  Maria Clara Fernandes, Alexander N. Shoushtari, Mario M. Leitao, M. Herman Chui, Hikmat Al-Ahmadie, Iva Petkovska> ;Journal of Medical Imaging and Radiation Oncology. 2021 Nov 30
• 6 citations
  Spectrum of BRAF Mutations and Gene Rearrangements in Ovarian Serous Carcinoma.
  M Herman Chui, Jason C. Chang, Yanming Zhang, Ahmet Zehir, Alison M. Schram, Jason A. Konner, Alexander Drilon, Arnaud Da Cruz Paula, Britta Weigelt, Rachel N. Grisham> ;JCO Precision Oncology. 2021 Sep 16
• 5 citations
  Somatic intronic TP53 c.375+5G mutations are a recurrent but under-recognized mode of TP53 inactivation.
  M Herman Chui, Ciyu Yang, Nikita Mehta, Vikas Rai, Ahmet Zehir, Amir Momeni Boroujeni, Marc Ladanyi, Diana Mandelker> ;The Journal of Pathology. Clinical Research. 2021 Sep 10
• 3 citations
  Paired Tumor-Normal Sequencing Provides Insights into TP53-Related Cancer Spectrum in Li-Fraumeni Patients.
  Ozge Ceyhan-Birsoy, Pier Selenica, M. Herman Chui, Gowtham Jayakumaran, Ryan Ptashkin, Maksym Misyura, Umut Aypar, Sowmya Jairam, Ciyu Yang, Yirong Li, Nikita Mehta, Y...> ;Journal of the National Cancer Institute. 2021 Jul 7
• Errayum: BRAFV600E-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma (Oncotarget. (2019) 10 (6870–6878) DOI: 10.1...
  M. Herman Chui, Susanne K. Kjaer, Kirsten Frederiksen, Charlotte Gerd Hannibal, Tian Li Wang, Russell Vang, Ie Ming Shih> ;Oncotarget. 2021 Jun 22
• 2 citations
  Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Tea...
  Thomas Boerner, Henry Walch, Bastien Nguyen, Alexia Iasonos, Qin C. Zhou, Nikolaus Schultz, M Herman Chui, Rachel N. Grisham, William P. Tew, Roisin E. O'Cearbhaill, C...> ;Gynecologic Oncology. 2021 Mar 1
• 14 citations
  Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma.
  M. Herman Chui, Amir Momeni Boroujeni, Diana Mandelker, Marc Ladanyi, Robert A. Soslow> ;Modern Pathology. 2021 Feb 1
• 20 citations
  Multi-Institutional Prospective Validation of Prognostic mRNA Signatures in Early Stage Squamous Lung Cancer (Alliance)
  Raphael Bueno, William G. Richards, David H. Harpole, Karla V. Ballman, Ming-Sound Tsao, Zhengming Chen, Xiaofei Wang, Guoan Chen, Lucian R. Chirieac, M. Herman Chui, ...> ;Journal of Thoracic Oncology. 2020 Nov 1
• 14 citations
  Oncogenic BRAF and KRAS mutations in endosalpingiosis.
  Michael Herman Chui, Ie Ming Shih> ;The Journal of Pathology. 2020 Feb 1
• 7 citations
  -mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma.
  M Herman Chui, Susanne K Kjaer, Kirsten Frederiksen, Charlotte G Hannibal, Tian-Li Wang, Russell Vang, Ie-Ming Shih> ;Oncotarget. 2019 Dec 3
• 14 citations
  Chromosomal instability and mTORC1 activation through PTEN loss contribute to proteotoxic stress in ovarian carcinoma
  M. Herman Chui, Sasha A. Doodnauth, Natalie Erdmann, Rodger E. Tiedemann, Fabrice Sircoulomb, Ronny Drapkin, Patricia Shaw, Robert Rottapel> ;Cancer Research. 2019 Nov 1
• 29 citations
  Clinicopathologic and Molecular Features of Paired Cases of Metachronous Ovarian Serous Borderline Tumor and Subsequent Serous Carcinoma.
  Michael Herman Chui, Deyin Xing, Felix Zeppernick, Zoe Q. Wang, Charlotte Gerd Hannibal, Kirsten Frederiksen, Susanne K. Kjaer, Leslie Cope, Robert J. Kurman, Ie Ming ...> ;The American Journal of Surgical Pathology. 2019 Nov 1
• 63 citations
  Loss of ARID1A in tumor cells renders selective vulnerability to combined ionizing radiation and PARP inhibitor therapy
  Youngran Park, M. Herman Chui, Yohan Suryo Rahmanto, Zheng Cheng Yu, Raghavendra A. Shamanna, Marina A. Bellani, Stephanie Gaillard, Ayse Ayhan, Akila N. Viswanathan, ...> ;Clinical Cancer Research. 2019 Sep 15
• 1 citations
  Cytomorphologic and molecular analyses of fallopian tube fimbrial brushings for diagnosis of serous tubal intraepithelial carcinoma
  M. Herman Chui, Russell Vang, Tian Li Wang, Ie Ming Shih, Christopher J. VandenBussche> ;Cancer Cytopathology. 2019 Mar 1
• 60 citations
  Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung Carcinoma
  Hui Yu, Zhengming Chen, Karla V. Ballman, Mark A. Watson, Ramaswamy Govindan, Irena Lanc, David G. Beer, Raphael Bueno, Lucian R. Chirieac, Michael Herman Chui, Guoan ...> ;Journal of Thoracic Oncology. 2019 Jan 1
• 31 citations
  Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma.
  Ting Tai Yen, Tsutomu Miyamoto, Shiho Asaka, M. Herman Chui, Yeh Wang, Shiou Fu Lin, Rebecca L. Stone, Amanda N. Fader, Ryoichi Asaka, Hiroyasu Kashima, Tanri Shiozawa...> ;Gynecologic Oncology. 2018 Sep 1
• 6 citations
  Genomic profiling identifies GPC5 amplification in association with sarcomatous transformation in a subset of uterine carcinosarcomas
  M. Herman Chui, Cherry Have, Lien N. Hoang, Patricia Shaw, Cheng-Han Lee, Blaise Clarke> ;The Journal of Pathology. Clinical Research. 2018 Jan 1
• Join now to see all